336 related articles for article (PubMed ID: 17439894)
21. Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece.
Deretzi G; Kountouras J; Koutlas E; Zavos C; Polyzos S; Rudolf J; Grigoriadis N; Gavalas E; Boziki M; Tsiptsios I
Mult Scler; 2010 Sep; 16(9):1091-101. PubMed ID: 20639270
[TBL] [Abstract][Full Text] [Related]
22. Men transmit MS more often to their children vs women: the Carter effect.
Kantarci OH; Barcellos LF; Atkinson EJ; Ramsay PP; Lincoln R; Achenbach SJ; De Andrade M; Hauser SL; Weinshenker BG
Neurology; 2006 Jul; 67(2):305-10. PubMed ID: 16864824
[TBL] [Abstract][Full Text] [Related]
23. Genes, environment, and susceptibility to multiple sclerosis.
Sotgiu S; Pugliatti M; Fois ML; Arru G; Sanna A; Sotgiu MA; Rosati G
Neurobiol Dis; 2004 Nov; 17(2):131-43. PubMed ID: 15474351
[TBL] [Abstract][Full Text] [Related]
24. Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis.
Harirchian MH; Fatehi F; Sarraf P; Honarvar NM; Bitarafan S
Mult Scler Relat Disord; 2018 Feb; 20():43-47. PubMed ID: 29291483
[TBL] [Abstract][Full Text] [Related]
25. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
[TBL] [Abstract][Full Text] [Related]
26. [Genetic predisposition for multiple sclerosis].
Fontaine B; Clerget-Darpoux F
Pathol Biol (Paris); 2000 Feb; 48(1):87-92. PubMed ID: 10729916
[TBL] [Abstract][Full Text] [Related]
27. The genetics and genetic epidemiology of multiple sclerosis: the "hard facts".
Sadovnick AD
Adv Neurol; 2006; 98():17-25. PubMed ID: 16400824
[No Abstract] [Full Text] [Related]
28. Environmental risk factors for multiple sclerosis. Part I: the role of infection.
Ascherio A; Munger KL
Ann Neurol; 2007 Apr; 61(4):288-99. PubMed ID: 17444504
[TBL] [Abstract][Full Text] [Related]
29. Epidemiologic studies of multiple sclerosis: a review.
Kahana E
Biomed Pharmacother; 2000 Mar; 54(2):100-2. PubMed ID: 10759294
[TBL] [Abstract][Full Text] [Related]
30. Maternal transmission of multiple sclerosis in a dutch population.
Hoppenbrouwers IA; Liu F; Aulchenko YS; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
Arch Neurol; 2008 Mar; 65(3):345-8. PubMed ID: 18332246
[TBL] [Abstract][Full Text] [Related]
31. T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population.
Carvalho A; Santos M; Maciel P; Rodrigues F
Mult Scler; 2008 May; 14(4):550-2. PubMed ID: 18208876
[TBL] [Abstract][Full Text] [Related]
32. [Familial multiple sclerosis: study of 2 cases of a northern African family].
Ben Hamouda IB; Mrabet A; Fredj M; Gouilder R
Rev Neurol (Paris); 1997 May; 153(4):278-81. PubMed ID: 9296149
[TBL] [Abstract][Full Text] [Related]
33. [A case-control study of the influence of the smoking behaviour in multiple sclerosis].
Rodríguez Regal A; del Campo Amigo M; Paz-Esquete J; Martínez Feijoo A; Cebrián E; Suárez Gil P; Mouriño MA
Neurologia; 2009 Apr; 24(3):177-80. PubMed ID: 19418294
[TBL] [Abstract][Full Text] [Related]
34. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland.
Greve B; Simonenko R; Illes Z; Peterfalvi A; Hamdi N; Mycko MP; Selmaj KW; Rozsa C; Rajczy K; Bauer P; Berger K; Weissert R
Mult Scler; 2008 Mar; 14(2):153-8. PubMed ID: 17942509
[TBL] [Abstract][Full Text] [Related]
35. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
[TBL] [Abstract][Full Text] [Related]
36. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
[TBL] [Abstract][Full Text] [Related]
37. HLA-DRB1 and multiple sclerosis in Malta.
Dean G; Yeo TW; Goris A; Taylor CJ; Goodman RS; Elian M; Galea-Debono A; Aquilina A; Felice A; Vella M; Sawcer S; Compston DA
Neurology; 2008 Jan; 70(2):101-5. PubMed ID: 18057318
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of multiple sclerosis in western Herzegovina.
Klupka-Sarić I; Ristić S; Sepcić J; Kapović M; Peterlin B; Materljan E; Jurisić T; Mamić DM; Burina A; Sulentić V
Clin Neurol Neurosurg; 2007 Nov; 109(9):779-83. PubMed ID: 17766036
[TBL] [Abstract][Full Text] [Related]
39. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect.
Poser CM
Clin Neurol Neurosurg; 2006 Mar; 108(3):227-33. PubMed ID: 16406307
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis.
Mamutse G; Woolmore J; Pye E; Partridge J; Boggild M; Young C; Fryer A; Hoban PR; Rukin N; Alldersea J; Strange RC; Hawkins CP
Mult Scler; 2008 Nov; 14(9):1280-3. PubMed ID: 18653739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
